Literature DB >> 15820951

Prions and the blood and immune systems.

Neil Mabbott1, Marc Turner.   

Abstract

Prion diseases take a number of forms in animals and humans. They are caused by conformational change in widely expressed prion protein leading to the formation of intracellular aggregates. Although the main focus of disease is the central nervous system, it is known that involvement of the immune system occurs in peripherally transmitted disease in particular. Animal experiments suggest that in some prion diseases follicular dendritic cells in the germinal centers are a major site of initial accumulation, and that abnormal prion protein and infectivity are detectable in peripheral lymphoid tissue from the earliest phase of disease. This raises the possibility that in a human peripherally transmitted prion disease like variant Creutzfeldt-Jakob disease, further transmission could occur through blood or tissue products or contamination of surgical instrumentation. Indeed two recent reports confirm that this disease has been transmitted by blood, raising significant public health concerns.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15820951

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  7 in total

1.  Production of cattle lacking prion protein.

Authors:  Jürgen A Richt; Poothappillai Kasinathan; Amir N Hamir; Joaquin Castilla; Thillai Sathiyaseelan; Francisco Vargas; Janaki Sathiyaseelan; Hua Wu; Hiroaki Matsushita; Julie Koster; Shinichiro Kato; Isao Ishida; Claudio Soto; James M Robl; Yoshimi Kuroiwa
Journal:  Nat Biotechnol       Date:  2006-12-31       Impact factor: 54.908

2.  Orally administered prion protein is incorporated by m cells and spreads into lymphoid tissues with macrophages in prion protein knockout mice.

Authors:  Ikuro Takakura; Kohtaro Miyazawa; Takashi Kanaya; Wataru Itani; Kouichi Watanabe; Shyuichi Ohwada; Hitoshi Watanabe; Tetsuya Hondo; Michael T Rose; Tsuyoshi Mori; Suehiro Sakaguchi; Noriyuki Nishida; Shigeru Katamine; Takahiro Yamaguchi; Hisashi Aso
Journal:  Am J Pathol       Date:  2011-07-18       Impact factor: 4.307

3.  Molecular structure of amyloid fibrils controls the relationship between fibrillar size and toxicity.

Authors:  Young Jin Lee; Regina Savtchenko; Valeriy G Ostapchenko; Natallia Makarava; Ilia V Baskakov
Journal:  PLoS One       Date:  2011-05-20       Impact factor: 3.240

4.  Paracrine diffusion of PrP(C) and propagation of prion infectivity by plasma membrane-derived microvesicles.

Authors:  Vincenzo Mattei; Maria Grazia Barenco; Vincenzo Tasciotti; Tina Garofalo; Agostina Longo; Klaus Boller; Johannes Löwer; Roberta Misasi; Fabio Montrasio; Maurizio Sorice
Journal:  PLoS One       Date:  2009-04-01       Impact factor: 3.240

5.  Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cells.

Authors:  Alessandro Corsaro; Adriana Bajetto; Stefano Thellung; Giulia Begani; Valentina Villa; Mario Nizzari; Alessandra Pattarozzi; Agnese Solari; Monica Gatti; Aldo Pagano; Roberto Würth; Antonio Daga; Federica Barbieri; Tullio Florio
Journal:  Oncotarget       Date:  2016-06-21

6.  Failure To Detect Prion Infectivity in Ticks following Prion-Infected Blood Meal.

Authors:  Ronald A Shikiya; Anthony E Kincaid; Jason C Bartz; Travis J Bourret
Journal:  mSphere       Date:  2020-09-02       Impact factor: 4.389

7.  Detailing the ultrastructure's increase of prion protein in pancreatic adenocarcinoma.

Authors:  Matteo Bianchini; Maria Anita Giambelluca; Maria Concetta Scavuzzo; Gregorio Di Franco; Simone Guadagni; Matteo Palmeri; Niccolò Furbetta; Desirée Gianardi; Niccola Funel; Claudio Ricci; Raffaele Gaeta; Luca Emanuele Pollina; Alfredo Falcone; Caterina Vivaldi; Giulio Di Candio; Francesca Biagioni; Carla Letizia Busceti; Luca Morelli; Francesco Fornai
Journal:  World J Gastroenterol       Date:  2021-11-14       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.